Sutro Biopharma Stock Forecast

Stock Price Forecast

The 7 analysts that cover Sutro Biopharma stock have a consensus rating of "Buy" and an average price target of $22.29, which forecasts a -5.43% decrease in the stock price over the next year. The lowest target is $8.00 and the highest is $30.

Price Target: $22.29 (-5.43%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$8.00	$22.29	$23	$30
Change	-66.06%	-5.43%	-2.42%	+27.28%

Analyst Ratings

The average analyst rating for Sutro Biopharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	0	0	0	1
Buy	1	1	1	2	2	3
Hold	5	5	6	5	5	2
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Hold → Buy Upgrades $8 → $27	Hold → Buy	Upgrades	$8 → $27	+14.55%	Mar 24, 2026
Andres Y. Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $10 → $28	Hold → Strong Buy	Upgrades	$10 → $28	+18.80%	Mar 24, 2026
Reni Benjamin Citizens	Citizens	Hold → Buy Upgrades $23	Hold → Buy	Upgrades	$23	-2.42%	Jan 20, 2026
Andres Y. Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $2 → $10	Hold	Maintains	$2 → $10	-57.57%	Dec 22, 2025
Derek Archila Wells Fargo	Wells Fargo	Hold Maintains $40 → $30	Hold	Maintains	$40 → $30	+27.28%	Aug 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

45.09M

from 102.48M

-56.00%

from 102.48M

Revenue Next Year

51.16M

from 45.09M

13.45%

from 45.09M

EPS This Year

-19.78

from -22.49

EPS Next Year

-13.92

from -19.78

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	61.88M	67.77M	153.73M	62.04M	102.48M	45.09M	51.16M
Revenue Growth	44.84%	9.52%	126.84%	-59.64%	65.18%	-56.00%	13.45%
EPS	-22.88	-23.49	-17.75	-29.61	-22.49	-19.78	-13.92
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	63.0M	80.6M
Avg	45.1M	51.2M
Low	9.8M	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-38.5%	78.7%
Avg	-56.0%	13.4%
Low	-90.4%	-

EPS Forecast

EPS	2026	2027
High	-4.46	-0.42
Avg	-19.78	-13.92
Low	-71.05	-38.22

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.